PharmaResearch (CEO Kim Thinkyou, Kang Ki-seok) announced the official entry into the Vietnamese market through the 'Rejuran Launch Symposium' held on May 17 at the Intercontinental Vietnam.

The symposium was attended by over 400 Vietnamese aesthetic experts and medical professionals who validated the excellence of Rejuran and engaged in in-depth discussions on its application methods.

'Rejuran' is a medical device aimed at improving facial wrinkles, made with salmon-derived regenerative substance PN (Polynucleotide) using DOT (DNA Fragment Optimizing Technology). DOT™ is PharmaResearch's proprietary patented technology used to manufacture and process DNA fragments to maximize the effectiveness of PDRN(Polydeoxyribo nucleotide)/PN.

During the symposium, five local and international doctors, including the key opinion leader (KOL) Dr. Michael J. Kim, and Vietnamese doctors Dr. Nguyen Vu Hoang, Dr. Pham Thi Uyen Nhi, Dr. Tran Nguyen Anh Tu, and Dr. Nguyen Quang Minh, highlighted the efficacy and safety of Rejuran and the superior quality of DOT®PN ingredients.

The event also featured the presentation of Korea’s latest aesthetic trends and expertise, led by Rejuran®, which was met with enthusiastic responses from the attendees.

A Pharmaresearch representative said, "We are delighted to introduce Rejuran's technological advancements to the Vietnamese market. Through this launch, we aim not only to expand significantly into the Vietnamese aesthetic market, but also to solidify Rejuran's position as a provider of innovative aesthetic solutions globally."

Since its launch in 2014, Rejuran® has established itself as a leading skin booster in South Korea and it has been registered and sold in more than 30 countries, including the United States, China, and Japan, continually expanding its global presence.

Media Contact
Company Name: PharmaResearch
Contact Person: Seohee Han
Email: Send Email
Country: South Korea
Website: http://pharmaresearch.co.kr/en